Similar articles

• The N-methyl-D-aspartate receptor and schizophrenia.

  Strous RD, Javitt DC. Strous RD, et al. Isr J Med Sci. 1996 May;32(5):275-81. Isr J Med Sci. 1996. PMID: 8641863 Review. No abstract available.
• Phencyclidine, NMDA receptor and schizophrenia.

  Nishikawa T, Tanii Y, Umino A, Hashimoto A, Hata N, Takashima M, Shirayama Y, Takahashi K. Nishikawa T, et al. Yakubutsu Seishin Kodo. 1991 Feb;11(1):65-9. Yakubutsu Seishin Kodo. 1991. PMID: 1831947 Review. No abstract available.
• Pharmacologic regulation of the NMDA receptor-ionophore complex.

  Johnson KM, Snell LD, Sacaan AI, Jones SM. Johnson KM, et al. NIDA Res Monogr. 1993;133:13-39. NIDA Res Monogr. 1993. PMID: 7694149 Review. No abstract available.
• Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.

  Javitt DC. Javitt DC. Int Rev Neurobiol. 2007;78:69-108. doi: 10.1016/S0074-7742(06)78003-5. Int Rev Neurobiol. 2007. PMID: 17349858 Review.
• [Development of animal models, and drug discovery for schizophrenia based on the glutamate hypothesis].

  Nabeshima T. Nabeshima T. Nihon Shinkei Seishin Yakurigaku Zasshi. 2010 Nov;30(5-6):195. Nihon Shinkei Seishin Yakurigaku Zasshi. 2010. PMID: 21322311 Japanese. No abstract available.